mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.075 |
0.09 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.09 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |